Bradykinin (BK) is a potent short-lived effector belonging to a class of peptides known as kinins. It participates in inflammatory and vascular regulation and processes including angioedema, tissue permeability, vascular dilation, and smooth muscle contraction. BK exerts its biological effects through the activation of the bradykinin B2 receptor (BKB2R) which is G-protein-coupled and is generally constitutively expressed. Upon binding, the receptor is activated and transduces signal cascades which have become paradigms for the actions of the Gai and Gaq G-protein subunits. Following activation the receptor is then desensitized, endocytosed, and resensitized. The bradykinin B1 (BKB1R) is a closely related receptor. It is activated by desArg 10 -kallidin or desArg 9 -BK, metabolites of kallidin and BK, respectively. This receptor is induced following tissue injury or after treatment with bacterial endotoxins such as lipopolysacharide or cytokines such as interleukin-1 or tumor necrosis factor-a. In this review we will summarize the BKB2R and BKB1R mediated signal transduction pathways. We will then emphasize the relevance of key residues and domains of the intracellular regions of the BKB2R as they relate to modulating its function (signal transduction) and selfmaintenance (desensitization, endocytosis, and resensitization). We will examine the features of the BKB1R gene promoter and its mRNA as these operate in the expression and self-maintenance of this inducible receptor. This communication will not cover areas discussed in earlier reviews pertaining to the actions of peptide analogs. For these we refer you to earlier reviews
Osteopontin is a multifunctional matricellular protein abundantly expressed during inflammation and repair. Osteopontin deficiency is associated with abnormal wound repair characterized by aberrant collagen fibrillogenesis in the heart and skin. Recent gene microarray studies found that osteopontin is abundantly expressed in both human and mouse lung fibrosis. Macrophages and T cells are known to be major sources of osteopontin. During lung fibrosis, however, osteopontin expression continues to increase when inflammation has receded, suggesting alternative sources of ostepontin during this response. In this study, we demonstrate immunoreactivity for osteopontin in lung epithelial and inflammatory cells in human usual interstitial pneumonitis and murine bleomycin-induced lung fibrosis. After treatment with bleomycin, osteopontin-null mice develop lung fibrosis characterized by dilated distal air spaces and reduced type I collagen expression compared with wild-type controls. There is also a significant decrease in levels of active transforming growth factor-beta(1) and matrix metalloproteinase-2 in osteopontin null mice. Type III collagen expression and total collagenase activity are similar in both groups. These results demonstrate that osteopontin expression is associated with important fibrogenic signals in the lung and that the epithelium may be an important source of osteopontin during lung fibrosis.
. NF-B induced by IL-1 inhibits elastin transcription and myofibroblast phenotype. Am J Physiol Cell Physiol 283: C58-C65, 2002; 10.1152/ ajpcell.00314.2001.-Interleukin (IL)-1 released after lung injury regulates the production of extracellular matrix components. We found that IL-1 treatment reduced the rate of elastin gene transcription by 74% in neonatal rat lung fibroblasts. Deletion analysis of the rat elastin promoter detected a cis-acting element located at Ϫ118 to Ϫ102 bp that strongly bound Sp1 and Sp3 but not nuclear factor (NF)-B. This element mediated IL-1-induced inhibition of the elastin promoter. IL-1 treatment did not affect the level of Sp1 but did induce translocation of the p65 subunit of NF-B. Overexpression of p65 decreased elastin promoter activity and markedly reduced elastin mRNA. Immunoprecipitation studies indicated an interaction between the p65 subunit and Sp1 protein. Microarray analysis of mRNA isolated after overexpression of p65 or treatment with IL-1 revealed downregulation of ␣-smooth muscle actin and calponin mRNAs. Expression of these genes is associated with the myofibroblast phenotype. These results indicate that IL-1 activates the nuclear localization of NF-B that subsequently interacts with Sp1 to downregulate elastin transcription and expression of the myofibroblast phenotype. nuclear factor-B; interleukin-1; Sp1 ELASTIN IS a major structural protein in the lung. It is found most notably in alveolar walls and blood vessels. Tropoelastin, a soluble precursor, is synthesized in alveolar structures by interstitial fibroblasts and in vascular tissue by smooth muscle cells (4,34,35). Elastin synthesis in the pulmonary parenchyma of the rodent lung is highest during alveolarization. This process usually begins in the postnatal period and decreases with maturity (4, 25). Disruption of elastin deposition during development results in failure of alveolar formation (19). In the adult lung parenchyma, elastin mRNA is minimally expressed in interstitial structures but can be reactivated during the development of pulmonary emphysema or fibrosis (18,20).We previously reported (20) that elastin and collagen mRNA levels are upregulated after bleomycin treatment of rodent lungs. This expression was confined primarily to myofibroblasts. The myofibroblast phenotype is characterized by ␣-smooth muscle actin expression (28). Myofibroblasts appear to be responsible for matrix deposition during wound healing (31). In the adult lung, elastin mRNA levels can be modulated by effector substances released from macrophages or resident interstitial cells or from the extracellular matrix after proteolytic injury. Elastin mRNA can be upregulated by insulin-like growth factor, transforming growth factor (TGF)-, and retinoic acid (13,16,22) and downregulated by basic fibroblast growth factor (7) and interleukin (IL)-1 (3).IL-1 affects gene transcription via several different families of trans-acting factors including AP-1 proteins, nuclear factor (NF)/IL-6-related factors [CCAAT box/enhancer b...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.